Home  >  Products  >  TCTA (T-cell leukemia translocation altered gene) Blocking Peptide (the middle region of protein) (100ug)
TCTA (T-cell leukemia translocation altered gene) Blocking Peptide (the middle region of protein) (100ug)

TCTA (T-cell leukemia translocation altered gene) Blocking Peptide (the middle region of protein) (100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-TCTA antibody (Catalogue #: ARP49704_P050) made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Presku: AAP49704
Size: 100 ug
Weight: 11kDa
Gene: 6988
Format: Lyophilized powder
Target: A chromosomal aberration, translocation t(1;3)(p34;p21), involving TCTA is associated with T-cell acute lymphoblastic leukemia (T-ALL).
See Full Product Listings >